1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Bioresorbable Polymers Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Bioresorbable Polymers Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Rising demand in medical applications
- 5.1.3 Increased focus on biodegradable products
- 5.1.4 Growth in surgical implant usage
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Expansion in tissue engineering solutions
- 5.2.3 Development of advanced drug delivery systems
- 5.2.4 Demand in orthopedic applications
5.3 Future Trends
- 5.3.1
- 5.3.2 Innovations in long-term resorbable polymers
- 5.3.3 Increased use in regenerative medicine
- 5.3.4 Focus on custom, patient-specific implants
5.4 Impact of Drivers and Restraints
6. North America Bioresorbable Polymers Market Regional Analysis
6.1 North America Bioresorbable Polymers Market Overview
6.2 North America Bioresorbable Polymers Market Revenue 2019-2028 (US$ Million)
6.3 North America Bioresorbable Polymers Market Forecast Analysis
7. North America Bioresorbable Polymers Market Analysis – by Type
7.1 Polylactic Acid
- 7.1.1 Overview
- 7.1.2 Polylactic Acid: North America Bioresorbable Polymers Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Polyglycolic Acid
- 7.2.1 Overview
- 7.2.2 Polyglycolic Acid: North America Bioresorbable Polymers Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Polydioxanone
- 7.3.1 Overview
- 7.3.2 Polydioxanone: North America Bioresorbable Polymers Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Polycaprolactone
- 7.4.1 Overview
- 7.4.2 Polycaprolactone: North America Bioresorbable Polymers Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: North America Bioresorbable Polymers Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Bioresorbable Polymers Market Analysis – by Application
8.1 Orthopedic Devices
- 8.1.1 Overview
- 8.1.2 Orthopedic Devices: North America Bioresorbable Polymers Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Drug Delivery
- 8.2.1 Overview
- 8.2.2 Drug Delivery: North America Bioresorbable Polymers Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Bioresorbable Polymers Market – North America Analysis
9.1 North America
- 9.1.1 North America Bioresorbable Polymers Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.1.1.1 North America Bioresorbable Polymers Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Bioresorbable Polymers Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Bioresorbable Polymers Market Breakdown, by Type
- 9.1.1.1.2 US: North America Bioresorbable Polymers Market Breakdown, by Application
- 9.1.1.2 Canada:
North America Bioresorbable Polymers Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Bioresorbable Polymers Market Breakdown, by Type
- 9.1.1.2.2 Canada: North America Bioresorbable Polymers Market Breakdown, by Application
- 9.1.1.3 Mexico :
North America Bioresorbable Polymers Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Bioresorbable Polymers Market Breakdown, by Type
- 9.1.1.3.2 Mexico : North America Bioresorbable Polymers Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Bioresorbable Polymers Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Evonik Industries AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Musashino Chemical Laboratory, Ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Ashland Global Holdings Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Poly-Med Incorporated
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Foster Corporation
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 REVA Medical, LLC
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Polysciences Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Bezwada Biomedical LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights